Hypoglycemia and Cardiovascular Risks
Open accessThe DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
Although hypoglycemia is the most common side effect of insulin therapy in diabetes and its morbidity is well known, for many years, the potentially life-threatening effects of hypoglycemia on the cardiovascular (CV) system have either been overlooked or have been dismissed as inconsequential to people with insulin-treated type 2 diabetes. This scenario may possibly be a consequence of the persisting misconception that this population is seldom exposed to severe hypoglycemia, defined as any episode that requires external assistance for recovery, whereas self-treated events are classified as “mild” (1). This myth was firmly repudiated by the findings of the large prospective study by the U.K. Hypoglycemia Study Group (2), which demonstrated that severe hypoglycemia is a common problem in insulin-treated type 2 diabetes and that the incidence increases with duration of insulin therapy. However, evidence for CV morbidity associated with hypoglycemia has been predominantly hypothetical and anecdotal (1,3). The potential dangers of intensive treatment regimens and strict glycemic control in people with type 2 diabetes who have CV disease (CVD) have now been highlighted by the disconcerting outcomes of recent studies (4–6), in which hypoglycemia was implicated in the excess mortality that was observed in some of these trials. It is therefore timely to review the effects of hypoglycemia on the CV system, how this major metabolic stress could precipitate major vascular events such as myocardial infarction and stroke, and its potential role in these recent clinical studies. In the adult human, acute hypoglycemia causes pronounced physiological responses as a consequence of autonomic activation, principally of the sympatho-adrenal system, and results in end-organ stimulation and a profuse release of epinephrine (adrenaline). This profound autonomic stimulus provokes hemodynamic changes, the important consequences of which are to maintain the supply of glucose to the brain and promote the hepatic …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is associated with increased heart rate, systolic blood pressure (BP), myocardial contractility, stroke volume and cardiac output, and can induce ST-and T-wave changes with a lengthening of the QT interval (slower repolarization), which may increase the risk of arrhythmias (67)(68)(69)(70)(71).”
From Hypoglycemia (2018) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 2×
“HYPOGLYCEMIA IN ACCORD, ADVANCE, AND VADT—CVD is the predominant cause of death in patients with type 2 diabetes, and reducing the risk of CVD has recently been the focus of three large glucose-lowering trials: ACCORD (Action to Control Cardiovascular Risk in Diabetes) (4), ADVANCE (Action in Diabetes and Vascular Dis…”
BackgroundResultIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“In a large multicenter randomized controlled trial in Australia (NICESUGAR) (35), the relationship of glycemic control to outcome from critical illness was examined in patients being treated in intensive care units.”
BackgroundGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“HYPOGLYCEMIA IN ACCORD, ADVANCE, AND VADT—CVD is the predominant cause of death in patients with type 2 diabetes, and reducing the risk of CVD has recently been the focus of three large glucose-lowering trials: ACCORD (Action to Control Cardiovascular Risk in Diabetes) (4), ADVANCE (Action in Diabetes and Vascular Dis…”
BackgroundA molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259 · cited 1×
“Those affected have abnormal cardiac repolarization represented by prolonged QT on their electrocardiograms and an increased risk of sudden death due to cardiac arrhythmias (26).”
BackgroundSevere hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096 · cited 1×
“Two meta-analyses (36,37) have shown that strict glycemic control in seriously ill patients does not improve overall survival but reduces the risk of septicemia in surgical intensive care units at the expense of a fivefold higher incidence of hypoglycemia (13.”
BackgroundBonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874 · cited 2×
“A study using the large U.K. General Practice Research Database (39) examined the relationship between HbA1c and survival using data collected for .20 years from 48,000 patients with type 2 diabetes.”
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540 · cited 10×
“In contrast to the ACCORD study, in VADT, a recent severe hypoglycemic event was an important predictor for CV death (HR 3.72; 95% CI 1.34–10.4; P , 0.01) and all-cause mortality (HR 6.37; 95%CI 2.57–15.8; P = 0.0001) as reported by Dr. William Duckworth and colleagues at the American Diabetes Association Scientific S…”
MethodInfluentialHypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435 · cited 2×
“This scenario may possibly be a consequence of the persisting misconception that this population is seldom exposed to severe hypoglycemia, defined as any episode that requires external assistance for recovery, whereas self-treated events are classified as “mild” (1).”
BackgroundSelf-citationMiller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429
Riddle, M. C., Ambrosius, W. T., Brillon, D. J., Buse, J. B., Byington, R. P., Cohen, R. M., Goff, D. C., Malozowski, S., Margolis, K. L., Probstfield, J. L., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1278 · Cited by 406 · cited 1×
“Thus, the ACCORD investigators concluded that symptomatic severe hypoglycemia does not appear to account for the difference in mortality between the two arms of the study up to the time when the ACCORD intensive glycemia arm was discontinued (43).”
BackgroundAssociation of Hypoglycemia and Cardiac Ischemia
Desouza, C., Salazar, H., Cheong, B., Murgo, J., & Fonseca, V. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1485 · Cited by 406 · cited 1×
“9 mmol/L [70 mg/dL]) were identified, 10 of which were accompanied by chest pain (13).”
BackgroundLong-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Skrivarhaug, T., Bangstad, H.-J., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0082-6 · Cited by 390
Kosiborod, M., Inzucchi, S. E., Krumholz, H. M., Xiao, L., Jones, P. G., Fiske, S., Masoudi, F. A., Marso, S. P., & Spertus, J. A. (2008) · Circulation · doi:10.1161/circulationaha.107.740498 · Cited by 385 · cited 1×
“This effect persisted after adjustment was made for potential confounding factors (31).”
BackgroundKosiborod, M. (2009) · JAMA · doi:10.1001/jama.2009.496 · Cited by 364 · cited 1×
“In another study, nondiabetic patients who developed spontaneous hypoglycemia while in hospital had a poorer outcome and a higher mortality than patients with insulin-treated diabetes exposed to iatrogenic hypoglycemia (34).”
ResultVascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 4×
“The hemodynamic changes associated with hypoglycemia include an increase in heart rate and peripheral systolic blood pressure, a fall in central blood pressure, reduced peripheral arterial resistance (causing a widening of pulse pressure), and increased myocardial contractility, stroke volume, and cardiac output (7).”
BackgroundInfluentialSelf-citationSvensson, A.-M., McGuire, D. K., Abrahamsson, P., & Dellborg, M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi230 · Cited by 310
Unexplained Deaths of Type 1 Diabetic Patients
Tattersall, R. B., & Gill, G. V. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01516.x · Cited by 309 · cited 1×
“SUDDEN DEATH IN YOUNG PEOPLE WITH TYPE 1 DIABETES—A link between hypoglycemia and sudden death was raised in the 1960s, but the first detailed description appeared in 1991 after investigation of a series of deaths of young adults with type 1 diabetes (14).”
BackgroundMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264 · cited 1×
“Hypoglycemia has long been known to affect the electrocardiogram (ECG) (9), causing ST wave changes with lengthening of the QT interval (10) and cardiac repolarization (11).”
BackgroundSelf-citationAntecedent Hypoglycemia Impairs Autonomic Cardiovascular Function
Adler, G. K., Bonyhay, I., Failing, H., Waring, E., Dotson, S., & Freeman, R. (2009) · Diabetes · doi:10.2337/db08-1153 · Cited by 216 · cited 2×
“The recent demonstration that brief periods of experimental hypoglycemia impair CV autonomic function for up to 16 h is additional evidence for a clinically relevant interaction (28).”
BackgroundBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Mortality in Childhood-Onset Type 1 Diabetes
Dahlquist, G., & Källén, B. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2384 · Cited by 157
Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus
Landstedt‐Hallin, L., Englund, A., Adamson, U., & Lins, P. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00528.x · Cited by 141 · cited 1×
“High-resolution electrocardiography, which measures the QT interval precisely, in conjunction with hypoglycemic clamps to control the depth of hypoglycemia, has demonstrated lengthening of the QT interval both in diabetic and nondiabetic individuals (20,21).”
BackgroundRobinson, R. T. C. E., Harris, N. D., Ireland, R. H., Macdonald, I. A., & Heller, S. R. (2004) · Diabetologia · doi:10.1007/s00125-003-1292-4 · Cited by 137 · cited 1×
“Clinical episodes of hypoglycemia have been shown to cause QT lengthening, measured using ambulatory ECG monitoring and simultaneous measurement of blood glucose (by either intermittent venous sampling or continuous glucose monitoring) (22).”
BackgroundSelf-citationZhang, Y., Han, H. J., Wang, J., Wang, H., Yang, B., & Wang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211044200 · Cited by 120 · cited 1×
“However, hypoglycemia induces a fall in serum potassium via sympathoadrenal activation and a direct effect of insulin, and hypoglycemia per se may have an effect by directly inhibiting cardiac ion channels that are responsible for potassium efflux during cardiac repolarization (25).”
BackgroundHypoglycaemia and Cardiac Arrhythmias in Patients with Type 2 Diabetes Mellitus
Lindström, T., Jorfeldt, L., Tegler, L., & Arnqvist, H. J. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01834.x · Cited by 113 · cited 1×
“When hypoglycemia was induced in six subjects with type 2 diabetes, five developed ischemic ECG changes, whereas a bradyarrhythmia resulted in loss of consciousness in another patient (12).”
BackgroundMortality in childhood-onset type 1 diabetes
Hadzhieva, E., Boyadzhieva, M., Iotova, V., Galcheva, S., Tsochev, Κ., Chalykova, T., Yotov, Y. T., Balev, B. D., Bocheva, Y., Usheva, N., et al. (2019) · Scripta Scientifica Medica · doi:10.14748/ssm.v51i1.5913 · Cited by 113
Schernthaner, G., Barnett, A. H., Betteridge, D. J., Carmena, R., Ceriello, A., Charbonnel, B. H., Hanefeld, M., Lehmann, R., Malecki, M. T., Nesto, R. W., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1702-3 · Cited by 107 · cited 3×
“5%, but without reference to specific antidiabetes treatments, diabetes duration, age of the patients, or preexisting CVD (46).”
BackgroundSelf-citationSartor, G., & Dahlquist, G. G. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00550.x · Cited by 91
Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes
Koivikko, M. L., Karsikas, M., Salmela, P. I., Tapanainen, J. S., Ruokonen, A., Seppänen, T., Huikuri, H. V., & Perkiömäki, J. S. (2008) · Diabetologia · doi:10.1007/s00125-007-0902-y · Cited by 89 · cited 1×
“Hypoglycemia has long been known to affect the electrocardiogram (ECG) (9), causing ST wave changes with lengthening of the QT interval (10) and cardiac repolarization (11).”
BackgroundInfluence of Autonomic Neuropathy on QTc Interval Lengthening During Hypoglycemia in Type 1 Diabetes
Lee, S. P., Yeoh, L., Harris, N. D., Davies, C. M., Robinson, R. T. C. E., Leathard, A. D., Newman, C. M. H., Macdonald, I. A., & Heller, S. R. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1535 · Cited by 89 · cited 1×
“However, not all data are supportive, since individuals with diabetic autonomic neuropathy actually have smaller increments inQT intervals during experimental hypoglycemia than individuals without (29).”
BackgroundSelf-citationPinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., & Gibson, C. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.034 · Cited by 82 · cited 1×
“5 mmol/L [81 mg/dL]) extremes of blood glucose measured on admission to hospitals, showing a U-shaped curve (32).”
BackgroundSchernthaner, G. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0748-7 · Cited by 80 · cited 1×
“The much lower risk for severe hypoglycemia in ADVANCE may be explained by the fact that the patients in that trial appeared to have earlier or less advanced diabetes, with a shorter duration by 2–3 years and lower HbA1c at entry despite very little use of insulin at baseline (40).”
BackgroundSelf-citationVessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia
Sommerfield, A. J., Wilkinson, I. B., Webb, D. J., & Frier, B. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00114.2007 · Cited by 75 · cited 1×
“15 years’ duration, arterial wall stiffness per se is greater and arteries are less elastic in response to hypoglycemia, manifesting in a lesser fall in central arterial pressure (8).”
BackgroundSelf-citationGonin, J. M., Kadrofske, M. M., Schmaltz, S., Bastyr, E. J., & Vinik, A. I. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.68 · Cited by 71 · cited 1×
“Diabetic autonomic neuropathy is known to be associated with an increased mortality, and resting QT intervals are generally longer in patients with autonomic neuropathy than in patients without (27).”
BackgroundEffects of adrenaline and potassium on QTc interval and QT dispersion in man
Lee, S., Harris, N. D., Robinson, R. T. C. E., Yeoh, L., Macdonald, I. A., & Heller, S. R. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01123.x · Cited by 71 · cited 1×
“Epinephrine infusion increases QT intervals (23), and b-blocking drugs attenuate QT lengthening during experimental hypoglycemia (24).”
BackgroundSelf-citationIshihara, M., Kojima, S., Sakamoto, T., Kimura, K., Kosuge, M., Asada, Y., Tei, C., Miyazaki, S., Sonoda, M., Tsuchihashi, K., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.055 · Cited by 63 · cited 1×
“A similar pattern was observed in patients with diabetes in the Japanese Acute Coronary Syndrome Study, but not in their nondiabetic group (33).”
ResultTu, E., Twigg, S. M., Duflou, J. A., & Semsarian, C. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01849.x · Cited by 60 · cited 2×
“An autopsy study from Australia (19) suggested that sudden unexpected deaths are four times more frequent than in a comparable nondiabetic population and, of these, many are found dead in an undisturbed bed.”
BackgroundDead in Bed Syndrome: a New Manifestation of Nocturnal Hypoglycaemia?
Campbell, I. W. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01507.x · Cited by 58 · cited 1×
“Most were found lying in an undisturbed bed, a scenario that prompted the label “dead in bed syndrome” (15).”
BackgroundEffect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes
Lee, S. P., Harris, N. D., Robinson, R. T., Davies, C., Ireland, R., Macdonald, I. A., & Heller, S. R. (2005) · Diabetologia · doi:10.1007/s00125-005-1796-1 · Cited by 45 · cited 1×
“Epinephrine infusion increases QT intervals (23), and b-blocking drugs attenuate QT lengthening during experimental hypoglycemia (24).”
BackgroundSelf-citationThe effects of insulin-induced hypoglycemia in patients with angina pectoris
Judson, W. E., & Hollander, W. (1956) · American Heart Journal · doi:10.1016/0002-8703(56)90259-9 · Cited by 33 · cited 6×
“Case reports describe angina in association with acute hypoglycemia and acute coronary syndromes with typical ECG and enzyme changes after severe hypoglycemia (3).”
BackgroundInfluentialEhara, N., Morimoto, T., Furukawa, Y., Shizuta, S., Taniguchi, R., Nakagawa, Y., Hoshino, K., Saito, N., Doi, T., Haruna, Y., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.024 · Cited by 11 · cited 1×
“Alarming results have been reported recently from a large multicenter registry of 3,571 Japanese patients undergoing first elective coronary revascularization (38) when a potential association was examined between preoperative HbA1c levels and the CV outcome.”
BackgroundMarques (1997) · doi:10.1002/(sici)1096-9136(199708)14:8<648::aid-dia418>3.0.co;2-1
Self-citation
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Efficacy and safety of degludec versus glargine in type 2 diabetes.
Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P.-M., Lange, M., Brown-Frandsen, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615692 · Cited by 574
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citation
Metadata
- Authors
- Frier, B. M., Schernthaner, G., & Heller, S. R.
- Affiliations
- Edinburgh Royal Infirmary (GB)
- Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
- Northern General Hospital (GB)
- Corresponding author
- Schernthaner, Guntram
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-04-22
- Volume
- 34
- Issue
- Supplement_2
- Pages
- S132-S137
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3632150
- OpenAlex
- W2004870840
- Cited by
- 381
- References
- 49
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 22 · 2023: 16 · 2022: 18 · 2021: 32 · 2020: 24 · 2019: 35 · 2018: 26 · 2017: 24 · 2016: 31 · 2015: 43 · 2014: 34 · 2013: 29 · 2012: 15
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypoglycemia, cardiovascular risk, type 2 diabetes, insulin therapy, severe hypoglycemia, myocardial infarction, stroke, autonomic responses, sympathoadrenal system, epinephrine, glycemic control, cardiovascular disease, mortality
- MeSH terms
- Cardiovascular Diseases, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.